muscle mass loss glp 1 Some people taking GLP-1 weight drugs are concerned about loss. In general, people with obesity have more muscle than people without obesity — simply because their bodies have to Balancing weight and muscle loss

doi: 10.1136/bmjdrc-2019-001025

Sengupta et al., 2019)

"Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats." Growth Hormone & IGF Research

Fillers are a component of multi-phase materials called nanocomposites, and they must be in the nanoscale range

These findings detail mechanisms of NRF2-dependent transcriptional regulation, pointing to noncanonical roles that extend beyond augmenting antioxidant capacity

Kidney outcome trials of SGLT2 inhibitors and GLP-1 receptor agonists in people with chronic kidney disease and diabetes mellitus Values are presented as number (%), meanstandard deviation, or estimate (95% CI)